Base
N2986412018-07-19New YorkClassification

The tariff classification of Bumetanide Tablets in dosage form, from Italy

U.S. Customs and Border Protection · CROSS Database · 1 HTS code referenced

Cross-Source Intelligence

Data compiled from CBP CROSS Rulings, Census Bureau Trade Data · As of 2026-04-29 · Updates monthly

Summary

The tariff classification of Bumetanide Tablets in dosage form, from Italy

Ruling Text

N298641 July 19, 2018 CLA-2-30:OT:RR:NC:N1:138 CATEGORY: Classification TARIFF NO.: 3004.90.9265 Mrs. Rhona M. Keeler NorthStar Healthcare 3300 Cork Airport Business Park Kinsale Road, Cork, T12 XN72 Ireland RE: The tariff classification of Bumetanide Tablets in dosage form, from Italy Dear Ms. Keeler: In your letter dated July 3, 2018, you requested a tariff classification ruling. The subject product, Bumetanide Tablets, is a medicinal preparation containing Bumetanide, a diuretic, as the active ingredient. It will be imported in tablet form in dosages of 0.5 mg, 1 mg and 2 mg. Bumetanide is indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease. The applicable subheading for the Bumetanide Tablets will be 3004.90.9265, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments (…) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal systems) or in the forms of packings for retail use: Other: Other: Other: Preparations primarily affecting the electrolytic, caloric or water balance: Diuretics.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on the World Wide Web at https://hts.usitc.gov/current. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at judy.h.lee@cbp.dhs.gov. Sincerely, Steven A. Mack Director National Commodity Specialist Division